Clinical Outcomes of a Treat and Extend Regimen with Intravitreal Aflibercept Injections in Patients with Diabetic Macular Edema: Experience in Clinical Practice

INTRODUCTION: Treat-and-extend (T&E) and pro re nata (PRN; ‘as needed’) regimens of intravitreal anti-vascular endothelial growth factor (VEGF) treatment have been found to reduce the injection burden on patients and improve the cost effectiveness of the treatment of macular edema. The aim of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Curry, Beverley A., Sanfilippo, Paul G., Chan, Sarah, Hewitt, Alexander W., Verma, Nitin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054518/
https://www.ncbi.nlm.nih.gov/pubmed/31755040
http://dx.doi.org/10.1007/s40123-019-00224-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054518/
https://www.ncbi.nlm.nih.gov/pubmed/31755040
http://dx.doi.org/10.1007/s40123-019-00224-x

Ejemplares similares